Skip to content

Biomarkable

Active
Private limited companyfounded 201115 yrs activeTuinwijklaan 43, 9000 Gent, BelgiumKBO/BCE: BE 0839.319.323
Summary

Biomarkable has been active since 2011 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €137,156 and a net result of -€7,217. Equity is growing by ~19.6% per year across the filed fiscal years. Its solvency ranks better than 84% of 7081 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.5% (low).

Checked score

Score 2025
Axes · tick = 2024
Profitability45▲+45
Solvency100=
Growth52=
Track record100
Bankruptcy probability, 12 months
0.5% Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €9,000 at 30 days acceptable
Liquidity ample (current ratio 14.67 against 5.59 in 2024; short-term debt: 3.9% and cash: 3.5% of total assets), and 13.6% of the assets are financed with debt.
Credit check for your own amount and term

Open the credit simulator : see how the verdict changes with amount, term and advance.

Signals

Three signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 15 years 0 20 y
raises risk · Persistent losses
Two consecutive loss-making years (2024 and 2025); equity is also lower. May indicate structural pressure on profitability.
NBB · annual accounts 2025
Net result per financial year
1819202122232425
2018 to 2025 · latest year -€7,217
neutral · Latest accounts filed on time
The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 30-04-2026, 0 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
on the day
2024
1 d early
2023
7 d early
2022
2 d early
2021
36 d early
2020
on the day
2019
1 d early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 7 days before the deadline; the sector median for financial year 2024 is 6 days before the deadline, and 36% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 30-09-2026 and is due by 30-04-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
27-09-2026 today30-09-2026 close30-04-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

Biomarkable was incorporated on 12 September 2011.1 Total assets rose from EUR 108,467 in 2018 to EUR 158,700 in 2025.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2018 and 2025

Go further with this company

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, micro schema

Equity
€137,156▼ 3.0%
2024 · €141,343
Total assets
€158,700▼ 13.4%
2024 · €183,160
Net result
-€7,217▲ 84.3%
2024 · -€45,984
Working capital
€83,965▼ 25.7%
2024 · €112,954
Trend over the years

Click a name to add, emphasise or remove a line.

Every figure with its change against the fiscal year before
favourable unfavourable
Line20212022202320242025
Operating result€87,052▲ 36.7%€175,213▲ 101%€69,950▼ 60.1%-€44,533-€8,681▲ 80.5%
Net result€59,416▲ 51.4%€121,899▲ 105%€49,289▼ 59.6%-€45,984-€7,217▲ 84.3%
Equity€99,024▲ 85.6%€162,351▲ 64.0%€205,926▲ 26.8%€141,343▼ 31.4%€137,156▼ 3.0%
Total assets€154,945▲ 10.4%€235,418▲ 51.9%€242,328▲ 2.9%€183,160▼ 24.4%€158,700▼ 13.4%
Debt€55,921▼ 35.7%€73,067▲ 30.7%€36,401▼ 50.2%€41,817▲ 14.9%€21,544▼ 48.5%
Working capital€51,886▲ 167%€124,664▲ 140%€159,364▲ 27.8%€112,954▼ 29.1%€83,965▼ 25.7%
Staff (FTE)
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
-€100,000€0€100,000€200,000Operating result 2021: €87,052€87,052Net result 2021: €59,416€59,416Operating result 2022: €175,213€175,213Net result 2022: €121,899€121,899Operating result 2023: €69,950€69,950Net result 2023: €49,289€49,289Operating result 2024: -€44,533-€44,533Net result 2024: -€45,984-€45,984Operating result 2025: -€8,681-€8,681Net result 2025: -€7,217-€7,21720212022202320242025-€50,000€0€50,000Operating result 2023: €69,950€69,900Net result 2023: €49,289€49,300Operating result 2024: -€44,533-€44,500Net result 2024: -€45,984-€46,000Operating result 2025: -€8,681-€8,680Net result 2025: -€7,217-€7,220202320242025
The operating result stays negative: a loss of €8,681 in 2025 against €44,533 in 2024; the loss shrinks.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €158,700
Fixed assets €68,590 ▲ 50.4%
Current assets €90,110 ▼ 34.5%
Equity and liabilities €158,700
Equity €137,156 ▼ 3.0%
Debt €21,544 ▼ 48.5%
Debt's share of the balance-sheet total falls from 22.8% to 13.6%. Equity and debt are lower.
Key figures and ratios
2025 value · change against 2024
EBITDA
€12,073▲
2024 · -€24,829
Cash flow
€13,538▲
2024 · -€26,279
Current ratio
14.67▲
2024 · 5.59
Debt to equity
0.16▼
2024 · 0.30
ROE
-5.3%▲
2024 · -32.5%
ROA
-4.5%▲
2024 · -25.1%
Interest coverage
3.83▲
2024 · -18.44
Debt ≤ 1 year
€6,144▼
2024 · €24,602
Debt > 1 year
€14,534▲
2024 · €9,845
Income taxes
€143▲
2024 · €127
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 6,916 companies that looked in July 2024 the way this one looks now, 1.1% went bankrupt within 24 months and 91% are still going.

  • Micro
  • 10 to 20 years old
  • solvency 30% or more
  • a small loss
1.1% went bankrupt
7.8% stopped otherwise
91% still going

A further 0.4% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a bankruptcy probability of 0.5% over twelve months; the group does not contradict it.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,058 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.4%
3 0.5% 0.5%
4 0.6% 0.7%
5 0.8% 0.9%
6 1.2% 1.3%
7 1.5% 1.6%
8 1.7% 1.7%
9 2.7% 2.8%
10 5.3% 5.7%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 6,916 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 48 lines
Balance sheet Code20242025
Assets
Total assets20/58€183,160€158,700▼
Fixed assets21/28€45,604€68,590▲
Tangible fixed assets22/27€45,604€68,590▲
Land and buildings22€23,258€36,483▲
Plant, machinery and equipment23€6,409€15,912▲
Furniture and vehicles24€15,937€16,195▲
Current assets29/58€137,556€90,110▼
Amounts receivable within one year40/41€38,922€24,499▼
Trade receivables40€25,994€19,190▼
Other amounts receivable41€12,928€5,308▼
Current investments50/53€49,500€59,999▲
Cash at bank and in hand54/58€49,134€5,612▼
Equity and liabilities
Total equity and liabilities10/49€183,160€158,700▼
Equity10/15€141,343€137,156▼
Contributions10/11€1€1=
Reserves13€174,860€174,860=
Distributable reserves133€174,860€174,860=
Profit (loss) carried forward14-€33,518-€37,705▼
Amounts payable17/49€41,817€21,544▼
Amounts payable after more than one year17€9,845€14,534▲
Financial debts170/4€9,845€14,534▲
Amounts payable within one year42/48€24,602€6,144▼
Current portion of amounts payable after more than one year42€4,210€4,311▲
Trade debts44€20,071€845▼
Suppliers440/4€20,071€845▼
Taxes, remuneration and social security45€210€143▼
Taxes450/3€210€143▼
Other amounts payable47/48€112€846▲
Accrued charges and deferred income492/3€7,370€866▼
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€19,705€20,755▲
Other operating charges640/8€1,147€916▼
Non-recurring operating charges66A-€569
Gross operating margin9900-€23,681€13,558▲
Operating profit (loss)9901-€44,533-€8,681▲
Financial income75/76B€22€4,758▲
Recurring financial income75€22€4,758▲
Financial charges65/66B€1,346€3,151▲
Recurring financial charges65€1,346€3,151▲
Profit (loss) for the period before taxes9903-€45,857-€7,074▲
Income taxes67/77€127€143▲
Profit (loss) for the period9904-€45,984-€7,217▲
Profit (loss) for the period to be appropriated9905-€45,984-€7,217▲
Appropriation of the result
Profit (loss) to be appropriated9906-€33,518-€37,705▼
Profit (loss) brought forward from the previous period14P€12,466-€30,488▼
Transfer to equity691/2€0-
To other reserves6921€0-
Profit to be distributed694/7€0-
Return on contributions (dividend)694€0-

The notes to these accounts (9 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20212022202320242025Change
Non-recurring operating income76A-€0----
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€15,606€18,116€19,061€19,705€20,755▲ 5.3%
Other operating charges640/8-€1,850€1,985€1,147€916▼ 20.2%
Non-recurring operating charges66A-€479€0-€569-
Gross operating margin9900€104,916€195,658€90,996-€23,681€13,558▲ 157%
Operating profit (loss)9901€87,052€175,213€69,950-€44,533-€8,681▲ 80.5%
Financial income75/76B-€1,130€1,838€22€4,758▲ 21,122%
Recurring financial income75€1,759€1,130€1,838€22€4,758▲ 21,122%
Financial charges65/66B-€3,591€1,331€1,346€3,151▲ 134%
Recurring financial charges65€5,229€3,591€1,331€1,346€3,151▲ 134%
Profit (loss) for the period before taxes9903€83,582€172,752€70,456-€45,857-€7,074▲ 84.6%
Income taxes67/77€24,166€50,854€21,167€127€143▲ 12.5%
Profit (loss) for the period9904€59,416€121,899€49,289-€45,984-€7,217▲ 84.3%
Profit (loss) for the period to be appropriated9905€59,416€121,899€49,289-€45,984-€7,217▲ 84.3%
Line20212022202320242025Change
Assets
Total assets20/58€154,945€235,418€242,328€183,160€158,700▼ 13.4%
Fixed assets21/28€69,317€55,851€60,617€45,604€68,590▲ 50.4%
Tangible fixed assets22/27€69,317€55,851€60,617€45,604€68,590▲ 50.4%
Land and buildings22-€37,656€33,085€23,258€36,483▲ 56.9%
Plant, machinery and equipment23-€828€2,758€6,409€15,912▲ 148%
Furniture and vehicles24-€17,368€24,774€15,937€16,195▲ 1.6%
Current assets29/58€85,628€179,566€181,711€137,556€90,110▼ 34.5%
Amounts receivable within one year40/41€27,883€5,435€43,742€38,922€24,499▼ 37.1%
Trade receivables40-€569€35,545€25,994€19,190▼ 26.2%
Other amounts receivable41-€4,866€8,197€12,928€5,308▼ 58.9%
Current investments50/53€80€80€49,500€49,500€59,999▲ 21.2%
Cash at bank and in hand54/58€57,664€174,051€88,469€49,134€5,612▼ 88.6%
Equity and liabilities
Total equity and liabilities10/49€154,945€235,418€242,328€183,160€158,700▼ 13.4%
Equity10/15€99,024€162,351€205,926€141,343€137,156▼ 3.0%
Contributions10/11-€18,600€18,600€1€1=
Reserves13€79,860€139,860€174,860€174,860€174,860=
Non-distributable reserves130/1-€1,860€0---
Reserves not available under the articles1311-€1,860€0---
Distributable reserves133-€138,000€174,860€174,860€174,860=
Profit (loss) carried forward14€564€3,891€12,466-€33,518-€37,705▼ 12.5%
Amounts payable17/49€55,921€73,067€36,401€41,817€21,544▼ 48.5%
Amounts payable after more than one year17€22,179€18,164€14,054€9,845€14,534▲ 47.6%
Financial debts170/4-€18,164€14,054€9,845€14,534▲ 47.6%
Amounts payable within one year42/48€33,742€54,902€22,347€24,602€6,144▼ 75.0%
Current portion of amounts payable after more than one year42-€4,015€4,110€4,210€4,311▲ 2.4%
Trade debts44€2,133€792€14,294€20,071€845▼ 95.8%
Suppliers440/4-€792€14,294€20,071€845▼ 95.8%
Taxes, remuneration and social security45-€47,624€1,838€210€143▼ 32.0%
Taxes450/3-€47,624€1,838€210€143▼ 32.0%
Remuneration and social security454/9-€0----
Other amounts payable47/48-€2,472€2,105€112€846▲ 657%
Accrued charges and deferred income492/3---€7,370€866▼ 88.3%
Line20212022202320242025Change
Profit (loss) for the period9904€59,416€121,899€49,289-€45,984-€7,217▲ 84.3%
+ Depreciation and write-downs630€15,606€18,116€19,061€19,705€20,755▲ 5.3%
Operating cash flow (approximation)€75,022€140,015€68,351-€26,279€13,538▲ 152%
Investment in fixed assets (approximation)--€4,651-€23,827-€4,692-€43,740▼ 832%
Change in cash-€116,387-€85,582-€39,335-€43,522▼ 10.6%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 30-04-2027
2026
30-04
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
2025
30-09
Financial Liquidity triplescurrent ratio 14.67
Current ratio from 5.59 to 14.67; short-term debt falls from €24,602 to €6,144.
29-04
NBB filing Annual accounts filed
fiscal year 2024 · micro schema
2024
30-09
Financial Weakest financial yearnet -€45,984
Net result drops to -€45,984, the lowest in the series; recovery starts the following year.
23-04
NBB filing Annual accounts filed
fiscal year 2023 · micro schema
2023
30-09
Financial Liquidity doublescurrent ratio 8.13
Current ratio from 3.27 to 8.13; short-term debt falls from €54,902 to €22,347.
30-09
Financial Equity above €200,000Eq €205,926 ▲26.8%
4 profitable years in a row build equity to €205,926.
28-04
NBB filing Annual accounts filed
fiscal year 2022 · micro schema
2022
30-09
Financial Highest result since 2018net €121,899 ▲105%
Operating result €175,213, net result €121,899, both a record.
30-09
Financial Equity above €150,000Eq €162,351 ▲64%
3 profitable years in a row build equity to €162,351.
25-03
NBB filing Annual accounts filed
fiscal year 2021 · micro schema
2021
30-04
NBB filing Annual accounts filed
fiscal year 2020 · micro schema
Show earlier events
2020
30-09
Financial Back to profitnet €39,235
Net result €39,235 after 2 loss-making years.
29-04
NBB filing Annual accounts filed
fiscal year 2019 · micro schema
2019
10-04
NBB filing Annual accounts filed
fiscal year 2018 · micro schema
2018
05-04
NBB filing Annual accounts filed
fiscal year 2017 · micro schema
2017
24-04
NBB filing Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 3 acts read
About the unread acts

We know of 3 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Gent · 1 establishment unit since 2011
seat establishment The establishment unit on the map
Ground area
208 m²
Building footprint
110 m²
Volume, LiDAR
765 m³
Parcel 44809I0606/00R003, Flanders · tallest building 12.4 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
Biomarkable
Tuinwijklaan 43, 9000 GentPrinting and reproduction of recorded media
since 20112.202.382.426
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
44809I0606/00R003 Flanders 208 m² 1 · 110 m² 12.3 m · 3 fl.
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

Of 13,417 companies in sector 73300 we hold annual accounts for 6,899. 5,488 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification
Legal formPrivate limited company
Founded12-09-2011
Fiscal year end30-09
Activities, NACEBEL 2025
73300Public relations and communication consultancy
72101Research and development on biotechnology
73110Advertising agencies
Contact
Phone 0497/173468Gent
E-invoicing
Reachable via Peppol
Peppol ID 0208:0839319323
Also 9925:BE0839319323
Registered 12-12-2024

Register as of 27 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.